National Institute of Health

Bethesda, Maryland 20892

6 studies enrolling now · 15 studies all time

What they study most

COVID-19, Cervical Cancer, Chronic Lymphocytic Leukemia (CLL), Common Variable Immunodeficiency (CVID), Diffuse Large B Cell Lymphoma (DLBCL), Erdheim-Chester Disease (ECD), Familial Partial Lipodystrophy, Follicular Lymphoma (FL), HPV-Related Carcinoma, HPV-Related Malignancy, High Grade Glioma, Immune Mediated Necrotizing Myopathy

Studies at this site

• Dabrafenib and/or Trametinib Rollover Study — Recruiting now
• A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies — Recruiting now
• PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer — Recruiting now
• ECD-Score: a Study on Erdheim-Chester Disease — Recruiting now
• Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation — Recruiting now
• Zopa Retreatment and Vector Shedding in Adults With RRP — Recruiting now
• Leniolisib for Immune Dysregulation in PIDs — Running, not enrolling
• Leniolisib for Immune Dysregulation in CVID — Running, not enrolling
• A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD) — Stopped early
• 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer — Stopped early
• Nemaline Myopathy Clinical Research Network (NM-CTRN) — Starting soon
• A Study to Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System — Completed
• Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy — Stopped early
• The National Institutes of Health Measure of Healing Experience of All Life Stressors — Completed
• Sildenafil for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury. — Completed